These results establish the presence of functional retinoid receptors in SMCs and document the growth-inhibitory action of atRA on these cells. Retinoid compounds, already in clinical use as antiproliferative agents for nonvascular indications, should be assessed further in in vivo models of intimal disease.
No takes yet. Share an insight, caveat, or question.
Miano et al. (1996) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: